Men with prostate cancer willing to accept lower survival odds to avoid side effects

Men who have been newly diagnosed with prostate cancer say they would trade some improvement in their odds of survival for improvements in side effects and quality of life, according to research presented at the 2018 NCRI Cancer Conference. Prostate cancer is one of the most common forms of the disease in men but in many cases it is a […]

Read more

Hypofractionated Radiation OK for Localized Prostate CA

MONDAY, Oct. 29, 2018 — A new clinical guideline for early-stage prostate cancer supports the use of shortened courses of radiation therapy, according to an article published in Practical Radiation Oncology. Scott C. Morgan, M.D., from the University of Ottawa in Canada, and colleagues conducted a systematic literature review to develop recommendations regarding moderately hypofractionated (240-340 cGy per fraction) and […]

Read more